Ondero Met 2.5 mg/500 mg Tablet is a dual-action oral antidiabetic medication used to manage type 2 diabetes mellitus. It combines Linagliptin, a DPP-4 inhibitor that helps increase insulin release in response to blood glucose, with Metformin, which decreases glucose production in the liver and improves insulin sensitivity. Together, they help stabilize blood sugar levels.
By maintaining effective glycemic control, this medicine helps reduce the long-term risk of diabetic complications such as nerve damage, kidney disease, and vision problems. For the best clinical outcomes, it should be taken alongside a balanced diet and regular physical activity. Ensure you follow your doctor’s dosage instructions strictly and report any symptoms of persistent stomach pain or unusual fatigue immediately.







































































